Analog Devices, Inc. Form 10-Q Summary
Business context and reporting period
Analog Devices designs, manufactures and markets integrated circuits, reported as one operating segment. This quarterly report covers the three and six months ended May 1, 2021, compared with the periods ended May 2, 2020. Fiscal 2021 is a 52- or 53-week year ending October 30, 2021.
Financial performance and key metrics
| Metric | Three months ended May 1, 2021 | Year-over-year change | Six months ended May 1, 2021 | Year-over-year change |
|---|---|---|---|---|
| Revenue | $1.661 billion | 26% | $3.220 billion | 23% |
| Gross margin | $1.137 billion; 68.4% | Up 410 bps | $2.182 billion; 67.8% | Up 310 bps |
| Operating income | $520 million; 31.3% of revenue | Up 51% | $984 million; 30.5% | Up 59% |
| Net income | $423 million; 25.5% of revenue | Up 58% | $811 million; 25.2% | Up 72% |
| Diluted EPS | $1.14 | Up $0.42 | $2.18 | Up $0.91 |
| Operating cash flow | Not separately provided | — | $1.164 billion | Up from $779 million |
Revenue growth was led by Industrial revenue, up 36% in the quarter and 30% year to date, and Automotive revenue, up 42% and 30%, respectively. Communications revenue was approximately flat in the quarter and up 8% year to date; Consumer revenue increased 8% and 6%, respectively. Distributors represented 66% of quarterly revenue and 63% of year-to-date revenue, compared with 57% in both prior-year periods.
R&D expense increased 20% in the quarter and 16% year to date, while SMG&A expense increased 46% and 15%, respectively. Quarterly SMG&A included $23.0 million of Maxim transaction costs; year-to-date SMG&A included $38.2 million. The six-month comparison also benefited from the absence of a $40.0 million charitable contribution recorded in the prior-year period.
Cash flow, balance sheet, debt and liquidity
- Cash and cash equivalents were $1.305 billion at May 1, 2021, up from $1.056 billion at October 31, 2020. Approximately $498.4 million was held in the United States.
- Six-month operating cash flow was $1.164 billion, investing cash flow was negative $135.8 million and financing cash flow was negative $783.4 million.
- Capital expenditures were $126.6 million for the first six months. Management expects fiscal 2021 capital expenditures to be 4% to 5% of fiscal 2021 revenue.
- Total debt principal was $5.175 billion, including $1.324 billion classified as current and $3.824 billion classified as long term on the balance sheet. The debt includes a $925 million term loan due March 2022 and $400 million of notes due December 2021.
- The company had a $1.25 billion unsecured revolving credit facility expiring June 2024 and was in compliance with applicable debt covenants and leverage requirements.
- Accounts receivable increased 10% from fiscal year-end to $814.1 million; inventory increased 5% to $641.2 million. Days sales outstanding remained 45 days, while days of cost of sales in inventory declined to 109 days from 116 days.
- The company paid $483.6 million of dividends and repurchased $345.9 million of common stock during the first six months. Approximately $1.6 billion remained available under the repurchase authorization.
Material changes, outlook and unusual items
Management attributed the improved results primarily to stronger broad-based demand, particularly in Industrial and Automotive, and higher factory utilization. Higher utilization increased gross margin by 410 basis points in the quarter and 310 basis points year to date.
Analog Devices expects quarterly dividends to continue, subject to Board approval and future financial conditions. On May 18, 2021, the Board declared a $0.69-per-share dividend, expected to total approximately $254.5 million. Management stated that available liquidity, operating cash generation and financing sources should fund operations, capital expenditures, R&D, Maxim transaction costs and dividends for at least the next twelve months.
The company continues to pursue its proposed approximately $25.0 billion all-stock acquisition of Maxim Integrated Products. Required approvals had been received in all jurisdictions except China as of the filing. The transaction includes a potential $830.0 million regulatory termination fee if the agreement is terminated in specified circumstances. The merger agreement may be terminated if not completed by July 12, 2021, subject to possible extensions. Transaction-related costs totaled $38.2 million year to date.
Restructuring and facility-consolidation activities remain in progress. Cumulative special charges through May 1, 2021 were $137.5 million for workforce repositioning and $55.7 million for consolidating facilities acquired with Linear Technology. The Hillview facility in California was planned for closure in fiscal 2021, and Singapore testing operations were expected to transition by the fiscal year ending October 29, 2022.
COVID-19 operations and supply chains had generally stabilized at normal levels since the third quarter of fiscal 2020, but management cannot quantify the pandemic's future impact. Principal risks include semiconductor cyclicality, supply and manufacturing constraints, distributor demand and credit exposure, export restrictions and U.S.-China tensions, foreign exchange and interest-rate changes, tax audits, cybersecurity, litigation, and the ability to complete and integrate the Maxim acquisition.
An Irish transfer-pricing assessment of approximately €43.0 million, or about $52.0 million at May 1, 2021, remains unresolved; the recorded liability was not material. An unfavorable ultimate outcome could materially increase future tax expense and reduce earnings.
Important facts for investors to verify
- Whether the Maxim acquisition obtained the remaining Chinese regulatory approval and closed by the applicable deadline, and the resulting share issuance, financing and integration costs.
- The maturity and refinancing plan for the $400 million notes due December 2021 and the $925 million term loan due March 2022.
- Whether strong Industrial and Automotive demand, factory utilization and gross-margin expansion are sustainable.
- Potential effects of COVID-19, semiconductor capacity constraints, third-party foundry dependence and supply-chain disruptions.
- Exposure to China-related export controls, trade restrictions and customer or distributor concentration.
- The outcome of the Irish transfer-pricing matter and other global tax audits.
- Progress and cash requirements for facility closures, restructuring and the planned Singapore asset sale.